providing 80mmol daily *Australian National Health and Medical Research Council Dietary Salt Study Management Committee Key features for bias assessment of randomised trials Citation Method of Allocation Blinding Loss to Use of Ceasing Reporting all Funding randomisation concealment follow-up early for outcome results source where benefit required Unclear risk (no Unclear risk (no Participants: <10% (low Yes (low risk) No (low risk) Unclear risk NHMRC description of description of unclear risk risk) (Reported that (low risk) (1989) method of method of there was no Providers: sequence concealment of significant change low risk generation) allocation) in cholesterol but did not report Outcome specific results) assessors: unclear risk Summary trial Citation Study Population Intervention Outcomes Sample size Compliance to Results & design level measured sodium target location of relevant to (urinary data) research question
providing 80mmol daily *Australian National Health and Medical Research Council Dietary Salt Study Management Committee Key features for bias assessment of randomised trials Citation Method of randomisation Allocation concealment Blinding Loss to follow-up Use of where required Ceasing early for benefit Reporting all outcome results Funding source (1989) Unclear risk (no description of method of sequence generation) Unclear risk (no description of method of concealment of allocation) Participants: unclear risk Providers: low risk Outcome assessors: unclear risk <10% (low risk) Yes (low risk) No (low risk) Unclear risk (Reported that there was no significant change in cholesterol but did not report specific results) NHMRC (low risk) Summary Citation & location Study design level of Population Intervention Outcomes measured relevant to research question Sample size Compliance to sodium target (urinary data) Results trial